THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Biogen Idec counts the votes

One Icahn nominee is set to be seated, second is uncertain

Investor Carl Icahn aims to seat Richard Mulligan (second from right) and Alex Denner (far right) on Biogen Idec's board. Investor Carl Icahn aims to seat Richard Mulligan (second from right) and Alex Denner (far right) on Biogen Idec's board. (Wendy Maeda/Globe Staff)
By Robert Weisman
Globe Staff / June 5, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

A day after adjourning its shareholders meeting without disclosing which candidates had won seats on its board, Biogen Idec Inc. conceded yesterday that investors probably had rebuked company executives and elected one of activist investor Carl C. Icahn's nominees. (Full article: 655 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass